- Apr 2, 2009
- 5,171
- 13,288
- 66
FDA issues Guidance for Industry and Investigators
Meetings with Industry and Investigators on the Research and Development of tobacco Products
Meetings with Industry and Investigators on the Research and Development of Tobacco Products
http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM305282.pdf
Please note that this guidance ONLY pertains to tobacco products regulated by Chapter IX of the FSPTCA (i.e. cigarettes, cigarette paper, RYO and smokeless tobacco products). It does NOT pertain to e-cigarettes, cigars, pipe tobacco, shisha/hookah, nicotine skin creams, nicotine dissolvables, etc. unless/until the FDA proposes and subsequently gives final approval to a "deeming" regulation.
Unfortunately, the FDA failed to mention this critically important fact in its new guidance, just as it has in many other guidances and regulations the agency has issued since 2009.
By confusing tobacco manufacturers and the public to believe that Chapter IX regulations currently apply to unregulated tobacco products, the FDA has been greasing the skids for railroading the "deeming" regulation through before providing any scientific evidence of any public health benefit of applying Chapter IX to currently unregulated products.
Yet another example of FDA trying to impose its "quit or die" regulatory agenda that conflicts with scientific and empirical evidence, ethics, human rights, consumer and public health.
Meetings with Industry and Investigators on the Research and Development of tobacco Products
Meetings with Industry and Investigators on the Research and Development of Tobacco Products
http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM305282.pdf
Please note that this guidance ONLY pertains to tobacco products regulated by Chapter IX of the FSPTCA (i.e. cigarettes, cigarette paper, RYO and smokeless tobacco products). It does NOT pertain to e-cigarettes, cigars, pipe tobacco, shisha/hookah, nicotine skin creams, nicotine dissolvables, etc. unless/until the FDA proposes and subsequently gives final approval to a "deeming" regulation.
Unfortunately, the FDA failed to mention this critically important fact in its new guidance, just as it has in many other guidances and regulations the agency has issued since 2009.
By confusing tobacco manufacturers and the public to believe that Chapter IX regulations currently apply to unregulated tobacco products, the FDA has been greasing the skids for railroading the "deeming" regulation through before providing any scientific evidence of any public health benefit of applying Chapter IX to currently unregulated products.
Yet another example of FDA trying to impose its "quit or die" regulatory agenda that conflicts with scientific and empirical evidence, ethics, human rights, consumer and public health.
Last edited: